1. Home
  2. NAUT

as 07-17-2024 1:36pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 337.0M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 84.3K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.55 EPS Growth: N/A
52 Week Low/High: $2.19 - $4.00 Next Earning Date: 07-30-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 8016.30%

NAUT Daily Stock ML Predictions

Stock Insider Trading Activity of Nautilus Biotechnolgy Inc. (NAUT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patel Sujal M NAUT CEO, President, and Secretary Mar 8 '24 Buy $2.84 12,044 $34,215.80 10,064,488 SEC Form 4
Patel Sujal M NAUT CEO, President, and Secretary Mar 8 '24 Buy $2.99 2,430 $7,262.06 10,052,444 SEC Form 4
Patel Sujal M NAUT CEO, President, and Secretary Mar 5 '24 Buy $2.65 7,405 $19,596.59 10,021,893 SEC Form 4
Patel Sujal M NAUT CEO, President, and Secretary Mar 5 '24 Buy $2.70 9,267 $25,033.87 10,031,160 SEC Form 4
Patel Sujal M NAUT CEO, President, and Secretary Mar 5 '24 Buy $2.89 18,854 $54,423.96 10,050,014 SEC Form 4

Share on Social Networks: